These are very early days for systematic genetic interaction studies in metazoans, and many questions – both theoretical and technical – remain unresolved. A notably unglamorous but important set of technical considerations is that differences in methodology between different studies in the same organism will heavily influence both the composition of reported datasets and conclusions drawn from them. Chief among these considerations, as illustrated by the 51 network variants identified by Byrne
et al. [
2] and comparisons with results from a similar study by Lehner
et al. [
27], is that differences in experimental design, scoring methods and models used to define genetic interactions [
24] will necessarily result in different sets of reported interactions. It is not yet clear how to evaluate these differences. Notably, both Byrne
et al. and Lehner
et al. achieved high technical reproducibility (83% and more than 90%, respectively); in contrast, when genetic alleles and RNAi for query-target pairs were reversed, only 40% (6/15) of reciprocal tests by Byrne
et al. interacted. This indicates that these screens may be far from saturation, as RNAi does not always phenocopy genetic alleles and can carry considerable false-negative rates [
34]. Unlike Lehner
et al. [
27], who placed a lower estimate of 32% on their detection rate for previously reported genetic interactions (some of which, for example suppressors, would not be expected to be detected as synthetic lethals), Byrne
et al. [
2] did not compare their results with a 'gold standard' of genetic interactions from the literature. Instead, they evaluated functional cohesion by precision and recall of shared GO terms, achieving somewhat lower precision but much higher recall (as well as a higher total number of interactions) among pairs tested in both studies. This and other comparisons suggest that the detection methods used by Lehner
et al. [
27] were more stringent, resulting in a bias toward stronger genetic interactions, and that Byrne
et al. [
2] cast a much wider net for recovery of genetic interactions.
A further improvement over the semi-quantitative scoring approach used by Byrne
et al. [
2], which was based on binned ranges of estimated survival rates, would be to precisely measure lethality in these assays. Currently, one of the biggest technical limitations for large-scale RNAi-based screens in
C. elegans is the lack of efficient high-throughput methods to quantitate lethality, growth rates, and other morphological phenotypes, which limits the extent to which issues surrounding the quantitative definition of genetic interactions [
23,
24] can be explored. Over time, as technical approaches evolve and further large-scale screens and in-depth studies accumulate, it will be interesting to revisit these comparisons.
A more profound question is, to what extent will patterns of genetic interactions be conserved across species? Answers to this question will inform how we use cross-species inferences to guide studies in less experimentally tractable systems. A preliminary comparison between worm and yeast [
2] suggested that, in contrast to PPIs, there is little conservation of genetic interactions between these two organisms. This conclusion is clouded, however, by caveats on several levels. For example, it is not clear if this comparison considered whether all of the positive genetic interaction pairs in
C. elegans were actually tested in yeast. Since the set of gene pairs that has been tested differs substantially between yeast and worm, tests of conservation should be made only for subsets of gene pairs that have been systematically tested in both organisms. More obvious is the dichotomy between unicellular and multicellular organisms: yeast are directly exposed to the environment, and must modulate their internal states accordingly, whereas metazoans comprise many different cell types with distinct internal states and external contacts. Measuring survival and growth rates thus provides a relatively direct readout of cell status in yeast, whereas the types of phenotypic assay performed in metazoans will heavily influence our ability to detect different patterns of genetic interactions. The interpretation of negative results in whole-animal assays is further complicated by the possibility – given a particular experimental setup or phenotypic assay – that two potentially interacting components may not become limiting in the same cell types, or that interactions in a subset of cells will not give rise to obvious organismal phenotypes. Studies of mammalian and
Drosophila cells in culture have begun to report genome-wide genetic requirements for specific cellular functions [
35,
36], but these cannot reveal how biological systems as a whole adapt to the loss of specific genetic determinants. Thus, the answer to whether genetic-interaction studies in model systems will provide practical insights into human biology and disease mechanisms awaits further studies. Good reason for optimism stems from the deep conservation of many developmental signaling pathways and the fact that many human disease processes can be effectively studied in these models (the fly and worm, for example, even provide model systems to study mechanisms underlying Alzheimer's disease [
37]).
What's next? Extending systematic genetic-interaction maps to other metazoan systems, including alleviating (suppressing) as well as synthetic (enhancing) interactions, using more specific high-throughput assays (for example, those that allow tissue-specific readouts [
38]), and developing quantitative assays, will greatly expand our understanding of molecular network organization in complex multicellular organisms. These approaches could also be combined with chemical genetic profiling, as pioneered in yeast [
21,
22], to develop therapeutic strategies based on multiple molecular targets within the cell. Experimental approaches for mapping genetic interactions will both inform and be guided by efforts to generate predictive models for both gene function and functional associations between genes (for example [
39,
40]): the continued accumulation of large unbiased training sets will help develop better predictive methods, which in turn will help fill out neighborhoods of interactions and reduce the combinatorial search space for studies directed at specific pathways. Finally, it will be interesting to compare the spectrum of phenotypes and genetic interactions identified in systematic studies of genetic alleles and RNAi with those arising from variation in natural populations (for example, see [
41]). Building on knowledge gained from decades of studying specific genes and pathways, global analysis of genetic-interaction networks promises to reveal new insights that will broadly influence our thinking about both applications to medicine and the relationship between network architecture and biological function.